T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Evolent Health
EVH
$527M
| $278K | ﹤0.01% |
22,568
+6,760
| +43% | +$95.3K |
|
|
PRGX
2302
DELISTED
PRGX Global, Inc.
PRGX
| $278K | ﹤0.01% |
39,200
| – | – |
|
|
HIBB
2303
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $278K | ﹤0.01% |
13,608
| – | – |
|
2304
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $276K | ﹤0.01% |
7,275
| – | – |
|
2305
The Bancorp
TBBK
$2.82B
| $276K | ﹤0.01% |
27,939
| – | – |
|
|
CRR
2306
DELISTED
Carbo Ceramics Inc.
CRR
| $276K | ﹤0.01% |
27,161
+2,225
| +9% | +$19.7K |
|
2307
Movado Group
MOV
$796M
| $275K | ﹤0.01% |
8,540
-4,700
| -35% | -$136K |
|
2308
Rio Tinto
RIO
$160B
| $275K | ﹤0.01% |
5,200
| – | – |
|
2309
Cerus
CERS
$572M
| $274K | ﹤0.01% |
81,000
-31,000
| -28% | -$105K |
|
2310
Natural Health Trends
NHTC
$15.4M
| $274K | ﹤0.01% |
18,010
-9,470
| -34% | -$179K |
|
2311
Waterstone Financial
WSBF
$385M
| $274K | ﹤0.01% |
16,050
+5,677
| +55% | +$106K |
|
2312
Cenovus Energy
CVE
$56.4B
| $273K | ﹤0.01% |
29,800
+700
| +2% | +$6.8K |
|
|
EXAC
2313
DELISTED
Exactech Inc
EXAC
| $273K | ﹤0.01% |
+5,530
| New | +$233K |
|
|
BBBY
2314
Bed Bath & Beyond
BBBY
$423M
| $271K | ﹤0.01% |
5,653
-11,180
| -66% | -$404K |
|
|
AFSI
2315
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $271K | ﹤0.01% |
26,951
-18,900
| -41% | -$214K |
|
|
FINL
2316
DELISTED
Finish Line
FINL
| $271K | ﹤0.01% |
+18,621
| New | +$201K |
|
|
ANCX
2317
DELISTED
Access National Corp
ANCX
| $268K | ﹤0.01% |
9,639
+2,300
| +31% | +$66K |
|
2318
Boise Cascade
BCC
$2.94B
| $267K | ﹤0.01% |
6,698
-10
| -0.1% | -$371 |
|
2319
Citizens
CIA
$198M
| $267K | ﹤0.01% |
36,361
| – | – |
|
2320
First Internet Bancorp
INBK
$256M
| $266K | ﹤0.01% |
6,960
-224
| -3% | -$8.37K |
|
|
MTSC
2321
DELISTED
MTS Systems Corp
MTSC
| $266K | ﹤0.01% |
+4,947
| New | +$266K |
|
|
CJ
2322
DELISTED
C&J Energy Services, Inc.
CJ
| $264K | ﹤0.01% |
7,890
-5,940
| -43% | -$179K |
|
2323
Park Aerospace
PKE
$811M
| $263K | ﹤0.01% |
13,360
| – | – |
|
2324
Sonida Senior Living
SNDA
$1.88B
| $261K | ﹤0.01% |
1,291
-767
| -37% | -$164K |
|
|
BNFT
2325
DELISTED
Benefitfocus, Inc.
BNFT
| $261K | ﹤0.01% |
+9,675
| New | +$268K |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.